Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
GermanyA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
GermanyStudy on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection
GermanyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
GermanyStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
GermanyLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
GermanyStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
GermanyGermanyEfficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
GermanyDose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis
GermanyStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
GermanyA study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
